Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166688237> ?p ?o ?g. }
- W2166688237 endingPage "1641" @default.
- W2166688237 startingPage "1633" @default.
- W2166688237 abstract "The anti-phospholipid syndrome (APS) is characterized by thrombosis and the presence of anti-phospholipid antibodies (aPL). Tissue factor (TF), the major initiator of the coagulation system, is induced on monocytes by aPL in vitro, explaining, in part, the pathophysiology in this syndrome. However, little is known regarding the nature of the aPL-induced signal transduction pathways leading to TF expression. In this study, we investigated aPL-inducible genes in PBMC using cDNA array system and real-time PCR. Our results indicated that the mitogen-activated protein kinase (MAPK) pathway was related to TF expression when PBMCs were treated, in the presence of β2Glycoprotein I (β2GPI), with human monoclonal anti-β2GPI antibodies [β2GPI-dependent anti-cardiolipin antibodies (aCL/β2GPI)]. Western blotting studies using monocyte cell line (RAW264.7) demonstrated that p38 MAPK protein was phosphorylated with nuclear factor κB (NF-κB) activation by monoclonal aCL/β2GPI treatment, and that SB203580, a specific p38 MAPK inhibitor, decreased the aCL/β2GPI-induced TF mRNA expression. The p38 MAPK phosphorylation, NF-κB translocation and TF mRNA expression triggered by aCL/β2GPI were abolished in the absence of β2GPI. These results demonstrated that the p38 MAPK signaling pathway plays an important role in aPL-induced TF expression on monocytes and suggest that the p38 MAPK may be a possible therapeutic target to modify a pro-thrombotic state in patients with APS." @default.
- W2166688237 created "2016-06-24" @default.
- W2166688237 creator A5001514470 @default.
- W2166688237 creator A5003587098 @default.
- W2166688237 creator A5008884910 @default.
- W2166688237 creator A5016009056 @default.
- W2166688237 creator A5026385112 @default.
- W2166688237 creator A5035085923 @default.
- W2166688237 creator A5053803963 @default.
- W2166688237 creator A5073548467 @default.
- W2166688237 creator A5079071350 @default.
- W2166688237 creator A5082645338 @default.
- W2166688237 date "2004-09-06" @default.
- W2166688237 modified "2023-10-18" @default.
- W2166688237 title "The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti- 2Glycoprotein I antibodies" @default.
- W2166688237 cites W1507631870 @default.
- W2166688237 cites W1515034676 @default.
- W2166688237 cites W1539669821 @default.
- W2166688237 cites W1567044188 @default.
- W2166688237 cites W1588051837 @default.
- W2166688237 cites W1623529898 @default.
- W2166688237 cites W1655860314 @default.
- W2166688237 cites W166703492 @default.
- W2166688237 cites W170573427 @default.
- W2166688237 cites W178032782 @default.
- W2166688237 cites W1846075936 @default.
- W2166688237 cites W1905168073 @default.
- W2166688237 cites W1969719203 @default.
- W2166688237 cites W1978609683 @default.
- W2166688237 cites W1980098897 @default.
- W2166688237 cites W1982207491 @default.
- W2166688237 cites W1986703193 @default.
- W2166688237 cites W1988948791 @default.
- W2166688237 cites W1993295284 @default.
- W2166688237 cites W1997101420 @default.
- W2166688237 cites W1997265458 @default.
- W2166688237 cites W2000055469 @default.
- W2166688237 cites W2002709892 @default.
- W2166688237 cites W2005106729 @default.
- W2166688237 cites W2005214515 @default.
- W2166688237 cites W2009686164 @default.
- W2166688237 cites W2019673194 @default.
- W2166688237 cites W2022999700 @default.
- W2166688237 cites W2026125323 @default.
- W2166688237 cites W2032716241 @default.
- W2166688237 cites W2034184306 @default.
- W2166688237 cites W2034560587 @default.
- W2166688237 cites W2037067246 @default.
- W2166688237 cites W2042087846 @default.
- W2166688237 cites W2042987988 @default.
- W2166688237 cites W2043746123 @default.
- W2166688237 cites W2046838002 @default.
- W2166688237 cites W2047362281 @default.
- W2166688237 cites W2053669774 @default.
- W2166688237 cites W2053890060 @default.
- W2166688237 cites W2054674683 @default.
- W2166688237 cites W2058984594 @default.
- W2166688237 cites W2066040502 @default.
- W2166688237 cites W2077468629 @default.
- W2166688237 cites W2093253402 @default.
- W2166688237 cites W2097210000 @default.
- W2166688237 cites W2101831374 @default.
- W2166688237 cites W2111607779 @default.
- W2166688237 cites W2113891001 @default.
- W2166688237 cites W2119330779 @default.
- W2166688237 cites W2129784243 @default.
- W2166688237 cites W2150608680 @default.
- W2166688237 cites W2153443293 @default.
- W2166688237 cites W2159553458 @default.
- W2166688237 cites W2160872701 @default.
- W2166688237 cites W2166393142 @default.
- W2166688237 cites W2300758794 @default.
- W2166688237 cites W2407548757 @default.
- W2166688237 cites W2409418092 @default.
- W2166688237 cites W2411442228 @default.
- W2166688237 cites W2416048862 @default.
- W2166688237 cites W2416213534 @default.
- W2166688237 cites W2423715988 @default.
- W2166688237 cites W2427423710 @default.
- W2166688237 cites W2468906932 @default.
- W2166688237 cites W2607741101 @default.
- W2166688237 cites W48454663 @default.
- W2166688237 doi "https://doi.org/10.1093/intimm/dxh166" @default.
- W2166688237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15466912" @default.
- W2166688237 hasPublicationYear "2004" @default.
- W2166688237 type Work @default.
- W2166688237 sameAs 2166688237 @default.
- W2166688237 citedByCount "117" @default.
- W2166688237 countsByYear W21666882372012 @default.
- W2166688237 countsByYear W21666882372013 @default.
- W2166688237 countsByYear W21666882372014 @default.
- W2166688237 countsByYear W21666882372015 @default.
- W2166688237 countsByYear W21666882372016 @default.
- W2166688237 countsByYear W21666882372017 @default.
- W2166688237 countsByYear W21666882372018 @default.
- W2166688237 countsByYear W21666882372019 @default.
- W2166688237 countsByYear W21666882372020 @default.
- W2166688237 countsByYear W21666882372021 @default.